DataMeds AI Reports Second Quarter 2026 Financials and Provides Business Update

Revenues grew 14% reaching $1.779M in Q2/26, beating management projectionsCorporate name change from Wellgistics Health, Inc. to DataMeds AI, Inc. in July 2026, which led to stock symbol change from ‘WGRX’ to ‘MEDS’ on NASDAQ Capital...

DataMEDS AI Announces Its Board of Directors Approved September 9, 2026 as the Payment Date of the Previously Announced Distribution of Dream Bowl Meme Coin I Tokens to Record Holders of Common Stock and other Eligible Equity Securities as of the Record Date of August 7, 2026

TAMPA, FL / ACCESS Newswire / August 14, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) (“DataMEDS AI,” “DataMEDS,” or the “Company”), an integrated healthcare company leveraging its Health IT infrastructure and artificial intelligence...

DataMeds AI Provides Update on Corexa Health’s Pharmacy Division

GLP-1 agonist drugs now availableIntegration of online store CorexaRx.com into Health Lives Here app now completeMedical foods Forzet™ & Galectovid™, and dietary supplement Tollovid® now availableRevenue stabilized above $600,000 for July 2026...

DataMeds AI Renames Pharmacy Subsidiaries Corexa Pharmacy and Corexa Tech & Hub Under New Corexa Health Division

TAMPA, FL / ACCESS Newswire / August 10, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) (“DataMeds AI,” “DataMEDS,” or the “Company”), a Health IT company leveraging its artificial intelligence platform EinsteinRx™ and...

DataMeds AI Reiterates 50:1 Dream Bowl Meme Coin Token to Common Shares Dividend Ratio with an August 7, 2026 Record Date

TAMPA, FL / ACCESS Newswire / August 6, 2026 / DataMeds AI, Inc. (NASDAQ:MEDS) (“DataMeds AI,” “DataMEDS,” or the “Company”), a Health IT company leveraging its artificial intelligence platform EinsteinRx™ and...